Patents matching “CTOR”

US 6312915

Tick (Ixodes scapularis) vector saliva-induced Lyme disease spirochete (Borrelia burgdorferi) antigens as vaccine candidates

Providence Plantation · Granted Nov 6, 2001 · Expires Nov 1, 2021

US 6309634

Methods of treating Parkinson's disease using recombinant adeno-associated vector (rAAV)

The Regents of the University of California · Granted Oct 30, 2001 · Expires Oct 25, 2021

US 6306598

Nucleic acid-coupled colorimetric analyte detectors

The Regents of the University of California · Granted Oct 23, 2001 · Expires Oct 18, 2021

US 6294379

Efficient AAV vectors

The Regents of the University of California · Granted Sep 25, 2001 · Expires Sep 20, 2021

US 6277593

Dorsal tissue affecting factor and compositions

THE REGENTS OF THE UNIV. OF CALIFORNIA · Granted Aug 21, 2001 · Expires Aug 16, 2021

US 6274702

Bone stimulating factor

Gensci Regeneration Science, Inc. · Granted Aug 14, 2001 · Expires Aug 9, 2021

US 6262047

Selective factor Xa inhibitors

COR Therapeutics, Inc. · Granted Jul 17, 2001 · Expires Jul 12, 2021

US 6245560

Vector with multiple target response elements affecting gene expression

The United States of America, as represented by the Department of Health and Human Services · Granted Jun 12, 2001 · Expires Jun 7, 2021

US 6245743

Inhibitors of factor Xa

COR Therapeutics, Inc. · Granted Jun 12, 2001 · Expires Jun 7, 2021

US 6228854

Selective factor Xa inhibitors

COR Therapeutics, Inc. · Granted May 8, 2001 · Expires May 3, 2021

US 6228600

Immunoassays for the alpha platelet-derived growth factor receptor

The United States of America, as represented by the Department of Health and Human Services · Granted May 8, 2001 · Expires May 3, 2021

US 6224879

Alphavirus expression vector

Bioption AB · Granted May 1, 2001 · Expires Apr 26, 2021

US 6225088

DNA encoding plasminogen-like growth factor (PLGF) and related embodiments

The United States of America, as represented by the Department of Health and Human Services · Granted May 1, 2001 · Expires Apr 26, 2021

US 6218382

Selective factor Xa inhibitors

COR Therapeutics, Inc. · Granted Apr 17, 2001 · Expires Apr 12, 2021

US 6211154

Ketoheterocyclic inhibitors of factor Xa

COR Therapeutics, Inc. · Granted Apr 3, 2001 · Expires Mar 29, 2021

US 6211183

Selective factor Xa inhibitors

COR Therapeutics, Inc. · Granted Apr 3, 2001 · Expires Mar 29, 2021

US 6204268

Selective factor Xa inhibitors

COR Therapeutics, Inc. · Granted Mar 20, 2001 · Expires Mar 15, 2021

US 6200811

Cell transformation vector comprising an HIV-2 packaging site nucleic acid and an HIV-1 GAG protein

The Regents of the University of California · Granted Mar 13, 2001 · Expires Mar 8, 2021

US 6197748

Ketoheterocyclic inhibitors of factor Xa

COR Therapeutics, Inc. · Granted Mar 6, 2001 · Expires Mar 1, 2021

US 6197578

Cells expressing both human CD4 and a human fusion accessory factor associated with HIV infection

The United States of America, as represented by the Department of Health and Human Services · Granted Mar 6, 2001 · Expires Mar 1, 2021

US 6194547

ETS2 repressor factor (ERF)

The United States of America, as represented by the Department of Health and Human Services · Granted Feb 27, 2001 · Expires Feb 22, 2021

US 6187313

Composition and method for treating and preventing helicobactor-pylori-associated stomach gastritis, ulcers and cancer

Nature's Sunshine Products, Inc. · Granted Feb 13, 2001 · Expires Feb 8, 2021

US 6174862

Neurotrophic peptides of activity dependent neurotrophic factor

The United States of America, as represented by the Department of Health and Human Services · Granted Jan 16, 2001 · Expires Jan 11, 2021

US 6171855

Vectors

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 9, 2001 · Expires Jan 4, 2021